Navigation Links
Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
Date:10/29/2008

Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's Web site: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development, manufacturing and commercialization including, but not limited to, the establishment in the market of VYVANSE(R) (lisdexamfetamine dimesylate) (Attention Deficit Hyperactivity Disorder ("ADHD")); the impact of competitive products, including, but not limited to, the impact of those on the Company's ADHD franchise; patents, including but not limited to, legal challenges relating to the Company's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine extended release) (ADHD); the Company's ability to secure new products for commercialization and/or development; the Company's proposed offer for Jerini AG, including but not limited to, the Company's ability to successfully complete the offer and integrate Jerini AG, as well as realize the anticipated benefits of the acquisition; and other risks and uncertainties detailed from time to time in the Company's
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
2. Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules
3. Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event
4. Presentations From Recent Heart Rhythm Society Meeting Validate the Safety and Efficacy of Ablation Frontiers Technology in 230 Patients
5. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
6. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
7. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
8. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
9. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
10. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
11. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... -- goBalto, Inc., the leading provider of cloud-based clinical study ... Red Herring,s Top 100 Global award. goBalto ... in 2013, marking its emergence as a top player ... Top 100 Global list has become a mark of ... Herring editors were among the first to recognize that ...
(Date:11/26/2014)... , Nov. 25, 2014  Medtronic,s roughly ... has been widely discussed in the media for ... creating a stronger leading player in one of ... Information.  The healthcare market research firm said  the ... feature a diverse set of solutions spanning inpatient ...
(Date:11/26/2014)... Heska Corporation (NASDAQ: HSKA ) - ( ... advanced veterinary diagnostic and other specialty veterinary products , announced ... The Benchmark Company, LLC,s Micro Cap Discovery Conference on Thursday, ... The Palmer House Hilton, 17 E. Monroe Street, ... Please email hska@haydenir.com or contact your Benchmark representative ...
Breaking Medicine Technology:goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Heska to Attend Benchmark Micro Cap Discovery Conference 2
... ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces that positive ... of ZIO-201 (isophosphoramide mustard,- IPM) to treat ... Society of Medical Oncology (ESMO) meeting held ... entitled, "Phase-I/II,Study of IPM (ZIO-201) In Advanced ...
... - TransPharma Medical,Ltd., a specialty pharmaceutical company ... products utilizing a proprietary,active transdermal drug delivery ... I clinical trials demonstrating the,safety and pharmacokinetic ... treatment of osteoporosis., A seven day, repeated ...
Cached Medicine Technology:Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 2TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 3
(Date:11/26/2014)... (PRWEB) November 26, 2014 The ... Cardiology have launched a partnership designed to improve ... for congestive heart failure (CHF) patients in the ... staff and Lourdes Cardiology team will help CHF ... supervised protocols. This partnership pairs the Cardiac Recovery ...
(Date:11/26/2014)... 2014 Increasing incidence rate of ... regulations are expected to be prime pharmacovigilance market ... of acute and chronic ailments has resulted in ... development. Moreover, growing adverse drug reaction related hospitalization ... become the need of the hour in the ...
(Date:11/26/2014)... NC (PRWEB) November 26, 2014 German ... of materials science can cause mesothelioma that looks and ... posted a new article on the research. Click ... the Fraunhofer Institute for Toxicology and Experimental Medicine in ... While all of the rats eventually developed ...
(Date:11/26/2014)... The city of San Diego, California, ... forward with a plan to recycle wastewater – also ... Kleyne supports the San Diego plan as part of ... to Kleyne, by recycling water that San Diego already ... be greatly reduced. (Spagat, E, “San Diego looks to ...
(Date:11/26/2014)... 2014 Loffler Companies has been selected ... Imaging, an online information and news publication for resellers ... sixth consecutive year Loffler has earned this prestigious award ... Elite Dealer Awards honor the best and the brightest ... Dealer honorees were chosen for their innovative marketing and ...
Breaking Medicine News(10 mins):Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 3Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2
... new modus operandi at Britain’s farm ministry, with a view ... in the bud, as a preparation before the autumn season. ... gulls and waders, seen as potential H5N1 disseminators of infection ... surveillance and testing in the areas frequented by migratory birds. ...
... adults are estimated to use complementary and alternative therapies ... results of a// national survey published in the September ... issue on sleep. ,Approximately 10 to 34 ... as insomnia, according to background information in the article. ...
... Thiruvananthapuram said that there was no need to panic after ... were reported in the city.// ,Health authorities said that ... to pelt the state. The chikungunya scare so far was ... be confined to some pockets as mosquitoes are increasing due ...
... mosquito-caused illness is causing panic in the city.// ,As per ... city but four patients with its symptoms are being treated. Their ... have already started a survey in the city to identify chikungunya ... medical officer D.C. Jain. ,However, there is panic in ...
... fires have forced over 1,300 people to leave their ... to battle// the hundreds of forest fires on Friday. ... worst that they have ever encountered at this time ... with smoke vulnerability like children, the elderly, the infirm ...
... study directed by Mount Sinai School of Medicine ... regimens// might halt or even reverse symptoms of ... Attenuates Alzheimer’s Disease Type Brain Amyloidosis in Squirrel ... will be published in the November 2006 issue ...
Cached Medicine News:Health News:About 5 Percent of Adults with Insomnia Use Alternative Therapies 2Health News:Chikungunya Outbreak Feared in Jaipur 2Health News:Burning fires in Northern Ontario Cause Hundreds to leave their Homes 2Health News:Calorie Restriction May Prevent, Reduce Alzheimer’s Neuropatholog 2
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... is a rapid ELISA test for Clostridium ... value and 99% sensitivity. That means the ... out C. difficile negatives - which can ... before culturing for the organism - and ...
... is a rapid immunoassay to detect Clostridium difficile ... test uses antibodies specific for toxins A and ... and >99% specificity compared to tissue culture. Because ... B, the risk of false negative results due ...
Medicine Products: